Although, CA 15-3, CA 19-9, CEA, and TPSA are still considered as excellent biomarkers for the early detection of BC, CRC and PCa, the levels of liver enzymes may serve as alternative indicators for the early detection of CRC and PCa. This evidence concerns the gene CEACAM5 and breast cancer.